Abstract
BackgroundBiologicals are the cornerstone for many treatment algorithms in inflammatory arthritis. While tumour necrosis factor (TNF) inhibitors may achieve important responses in ∼50% of patients with rheumatoid arthritis (RA) and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have